| Year |
Citation |
Score |
| 2019 |
Quinlan MA, Krout D, Katamish R, Robson MJ, Nettesheim C, Gresch PJ, Mash D, Henry K, Blakely RD. Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences. Acs Chemical Neuroscience. PMID 30668912 DOI: 10.1021/Acschemneuro.8B00689 |
0.492 |
|
| 2018 |
Stewart A, Davis GL, Gresch PJ, Katamish RM, Peart R, Rabil MJ, Gowrishankar R, Carroll FI, Hahn MK, Blakely RD. Serotonin transporter inhibition and 5-HT receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30578419 DOI: 10.1038/s41386-018-0301-8 |
0.425 |
|
| 2018 |
Gowrishankar R, Gresch PJ, Davis GL, Katamish RM, Riele JR, Stewart AM, Vaughan RA, Hahn MK, Blakely RD. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29739866 DOI: 10.1523/Jneurosci.0055-18.2018 |
0.311 |
|
| 2017 |
Simmler LD, Anacker AMJ, Levin MH, Vaswani NM, Gresch PJ, Nackenoff AG, Anastasio NC, Stutz SJ, Cunningham KA, Wang J, Zhang B, Keith Henry L, Stewart A, Veenstra-VanderWeele J, Blakely RD. Serotonin Transporter Blockade Contributes to the Behavioral, Neuronal, and Molecular Effects of Cocaine. British Journal of Pharmacology. PMID 28585320 DOI: 10.1111/Bph.13899 |
0.398 |
|
| 2016 |
Zhang Z, Shen M, Gresch PJ, Ghamari-Langroudi M, Rabchevsky AG, Emeson RB, Stamm S. Oligonucleotide-induced alternative splicing of serotonin 2C receptor reduces food intake. Embo Molecular Medicine. PMID 27406820 DOI: 10.15252/Emmm.201506030 |
0.517 |
|
| 2016 |
Wyler SC, Spencer WC, Green NH, Rood BD, Crawford L, Craige C, Gresch P, McMahon DG, Beck SG, Deneris E. Pet-1 Switches Transcriptional Targets Postnatally to Regulate Maturation of Serotonin Neuron Excitability. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 1758-74. PMID 26843655 DOI: 10.1523/Jneurosci.3798-15.2016 |
0.466 |
|
| 2014 |
Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proceedings of the National Academy of Sciences of the United States of America. 111: E4779-88. PMID 25331903 DOI: 10.1073/Pnas.1417294111 |
0.325 |
|
| 2014 |
Saunders C, Siuta M, Robertson SD, Davis AR, Sauer J, Matthies HJ, Gresch PJ, Airey DC, Lindsley CW, Schetz JA, Niswender KD, Veenstra-Vanderweele JM, Galli A. Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function. Neurochemistry International. 73: 113-21. PMID 24090638 DOI: 10.1016/J.Neuint.2013.09.015 |
0.774 |
|
| 2011 |
Thompson BJ, Jessen T, Henry LK, Field JR, Gamble KL, Gresch PJ, Carneiro AM, Horton RE, Chisnell PJ, Belova Y, McMahon DG, Daws LC, Blakely RD. Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proceedings of the National Academy of Sciences of the United States of America. 108: 3785-90. PMID 21282638 DOI: 10.1073/Pnas.1011920108 |
0.562 |
|
| 2010 |
Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, Polley DB, Veenstra-Vanderweele J, Stanwood GD, Magnuson MA, Niswender KD, et al. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. Plos Biology. 8: e1000393. PMID 20543991 DOI: 10.1371/Journal.Pbio.1000393 |
0.341 |
|
| 2010 |
Canal CE, Olaghere da Silva UB, Gresch PJ, Watt EE, Sanders-Bush E, Airey DC. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. Psychopharmacology. 209: 163-74. PMID 20165943 DOI: 10.1007/s00213-010-1784-0 |
0.609 |
|
| 2007 |
Hackler EA, Turner GH, Gresch PJ, Sengupta S, Deutch AY, Avison MJ, Gore JC, Sanders-Bush E. 5-Hydroxytryptamine2C receptor contribution to m-chlorophenylpiperazine and N-methyl-beta-carboline-3-carboxamide-induced anxiety-like behavior and limbic brain activation. The Journal of Pharmacology and Experimental Therapeutics. 320: 1023-9. PMID 17138863 DOI: 10.1124/Jpet.106.113357 |
0.666 |
|
| 2007 |
Gresch PJ, Barrett RJ, Sanders-Bush E, Smith RL. 5-Hydroxytryptamine (serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of d-lysergic acid diethylamide. The Journal of Pharmacology and Experimental Therapeutics. 320: 662-9. PMID 17077317 DOI: 10.1124/jpet.106.112946 |
0.671 |
|
| 2006 |
Tomlinson ID, Gies AP, Gresch PJ, Dillard J, Orndorff RL, Sanders-Bush E, Hercules DM, Rosenthal SJ. Universal polyethylene glycol linkers for attaching receptor ligands to quantum dots. Bioorganic & Medicinal Chemistry Letters. 16: 6262-6. PMID 17000112 DOI: 10.1016/J.Bmcl.2006.09.031 |
0.633 |
|
| 2005 |
Bentzen EL, Tomlinson ID, Mason J, Gresch P, Warnement MR, Wright D, Sanders-Bush E, Blakely R, Rosenthal SJ. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjugate Chemistry. 16: 1488-94. PMID 16287246 DOI: 10.1021/Bc0502006 |
0.496 |
|
| 2005 |
Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1693-702. PMID 15756304 DOI: 10.1038/sj.npp.1300711 |
0.648 |
|
| 2002 |
Gresch PJ, Strickland LV, Sanders-Bush E. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Neuroscience. 114: 707-13. PMID 12220572 DOI: 10.1016/S0306-4522(02)00349-4 |
0.706 |
|
| 2002 |
Smith RL, Gresch PJ, Barrett RJ, Sanders-Bush E. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release. Pharmacology, Biochemistry, and Behavior. 72: 77-85. PMID 11900772 DOI: 10.1016/S0091-3057(01)00723-7 |
0.718 |
|
| 2001 |
Campbell BM, Gresch PJ, Walker PD. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum. Neuroscience. 105: 671-80. PMID 11516832 DOI: 10.1016/S0306-4522(01)00218-4 |
0.521 |
|
| 1999 |
Gresch PJ, Walker PD. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease. Neuroscience. 93: 831-41. PMID 10473249 DOI: 10.1016/S0306-4522(99)00238-9 |
0.532 |
|
| 1999 |
Gresch PJ, Walker PD. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat. Brain Research. Molecular Brain Research. 70: 125-34. PMID 10381550 DOI: 10.1016/S0169-328X(99)00138-2 |
0.581 |
|
| 1999 |
Gresch PJ, Walker PD. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor. Brain Research. Molecular Brain Research. 67: 190-3. PMID 10101247 DOI: 10.1016/S0169-328X(99)00059-5 |
0.531 |
|
| Show low-probability matches. |